358 related articles for article (PubMed ID: 2114249)
1. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
3. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
4. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
5. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibitors.
Kirchain WR; Rendell MS
Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
[TBL] [Abstract][Full Text] [Related]
7. [Aldose-reductase inhibitors and cataract formation (author's transl)].
Keller G; Leuenberger PM
Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization for aldose reductase in diabetic lenses.
Akagi Y; Kador PF; Kinoshita JH
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
10. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix.
Aida K; Tawata M; Shindo H; Onaya T; Sasaki H; Yamaguchi T; Chin M; Mitsuhashi H
Planta Med; 1990 Jun; 56(3):254-8. PubMed ID: 2118267
[TBL] [Abstract][Full Text] [Related]
11. Current status of aldose reductase inhibitors.
Zimmerman BR
Diabetes Care; 1987; 10(1):123-5. PubMed ID: 3105984
[No Abstract] [Full Text] [Related]
12. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
13. [The role of polyol pathways in formation of diabetic cataracts].
Sabasiński K; Andrzejewska-Buczko J
Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
[TBL] [Abstract][Full Text] [Related]
14. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
15. [Aldose reductase inhibitors].
Dostert P; Strolin Benedetti M
J Pharmacol; 1986; 17(4):483-96. PubMed ID: 3104688
[TBL] [Abstract][Full Text] [Related]
16. Method for isolating tight-binding inhibitors of rat lens aldose reductase.
Sun G; Ma Y; Gao X; König S; Fales HM; Kador PF
Exp Eye Res; 2004 Dec; 79(6):919-26. PubMed ID: 15642330
[TBL] [Abstract][Full Text] [Related]
17. Discoveries in research on diabetic keratopathy.
Cisarik-Fredenburg P
Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
19. Implications of aldose reductase in cataracts in human diabetes.
Varma SD; Schocket SS; Richards RD
Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):237-41. PubMed ID: 106020
[TBL] [Abstract][Full Text] [Related]
20. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.
Madhu SV; Verma NP; Goel A; Kapoor VK
J Assoc Physicians India; 1992 Oct; 40(10):679-81. PubMed ID: 1307356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
